Vitamin B6 (P5P)
24 mg of pyridoxal-5’-phosphate — the active coenzyme form of B6 that requires no hepatic conversion — split across AM and PM to support catecholamine synthesis during the day and serotonin/GABA production overnight, covering the full neurotransmitter cycle that drives cognitive performance and recovery.
Primacy Research
What Vitamin B6 (P5P) Does For You
Neurotransmitter Synthesis Cofactor
P5P is the obligate coenzyme for AADC (dopamine, serotonin synthesis) and GAD (GABA synthesis) — the enzymes that convert amino acid precursors into the neurotransmitters governing focus, mood, anxiety regulation, and sleep quality.
Pre-Activated Coenzyme Form
Unlike standard pyridoxine, P5P requires no hepatic phosphorylation — bypassing the conversion bottleneck caused by aging, riboflavin deficiency, liver impairment, or PNPO genetic variants. Immediately functional as a coenzyme in every tissue it reaches.
Circadian Split-Dose Architecture
15 mg AM supports daytime catecholamine synthesis (dopamine, norepinephrine for focus and motivation). 9 mg PM supports nighttime serotonin and GABA synthesis (for sleep onset, mood stabilization, and recovery). Full neurotransmitter cycle coverage.
Homocysteine Reduction & Neuroprotection
P5P is required for the transsulfuration pathway that clears homocysteine — a key risk factor for cognitive decline and brain atrophy. The VITACOG trial showed a three-nutrient combination (B6 + B12 + folate) reduced brain atrophy by 30% in adults over 70 with MCI over 2 years — B6’s independent contribution cannot be determined.
Anxiety & Mood Support
A single RCT (Field et al., n=478) found high-dose pyridoxine (100 mg — not P5P) significantly reduced self-reported anxiety in young adults, consistent with its role in GABA synthesis — the primary inhibitory neurotransmitter that counteracts excitatory glutamate signaling.
Your Neurotransmitter Factory Is Rate-Limited
Vitamin B6 — specifically its active coenzyme form, pyridoxal-5’-phosphate (P5P) — is required for the synthesis of dopamine, serotonin, GABA, norepinephrine, and epinephrine. These five neurotransmitters collectively govern motivation, mood, focus, anxiety regulation, and sleep quality. Every synthesis step requires P5P as the obligate cofactor for the aromatic amino acid decarboxylase (AADC) reaction that converts amino acid precursors into active neurotransmitters. If P5P is insufficient, neurotransmitter production is rate-limited regardless of how much tryptophan, tyrosine, or glutamate is available.
Rate-Limiting Cofactor
P5P is the coenzyme that converts L-DOPA → dopamine, 5-HTP → serotonin, and glutamate → GABA. These are not optional reactions — they are the synthesis steps for the primary neurotransmitters governing motivation, mood, focus, and sleep. Insufficient P5P creates a bottleneck that downstream precursor availability cannot overcome.
25% of Adults Are Insufficient
Surveys of NHANES data show approximately 25% of U.S. adults have plasma PLP (pyridoxal phosphate) below the adequacy threshold. Standard B6 (pyridoxine) requires hepatic conversion to P5P — a step impaired by aging, alcohol use, riboflavin deficiency, and genetic variants. Many people consuming “enough” B6 by dietary standards are functionally insufficient at the coenzyme level.
Circadian Neurotransmitter Demand
Catecholamine demand (dopamine, norepinephrine) peaks during daytime alertness and cognitive work. Serotonin and GABA demand peaks during evening wind-down and sleep preparation. A single-dose B6 supplement cannot optimally support both phases. Splitting P5P across AM and PM aligns cofactor delivery with the neurotransmitter systems that are most active in each phase of the circadian cycle.
How Vitamin B6 (P5P) Works
P5P (pyridoxal-5’-phosphate) is the biologically active form of vitamin B6 — the form that directly functions as a coenzyme without requiring hepatic phosphorylation. It serves as the obligate cofactor for over 100 enzyme-catalyzed reactions, with its highest-impact role in neurotransmitter biosynthesis.
AADC Cofactor: Dopamine + Serotonin Synthesis
Aromatic amino acid decarboxylase (AADC) is the enzyme that converts L-DOPA to dopamine and 5-HTP to serotonin. P5P is the required coenzyme for both reactions. Without adequate P5P, AADC activity is directly constrained — and downstream neurotransmitter availability falls regardless of precursor supply. This is the central biochemical role that makes B6 status a rate-limiting factor in cognitive and mood performance.
GAD Cofactor: GABA Synthesis
Glutamic acid decarboxylase (GAD) converts glutamate to GABA — the primary inhibitory neurotransmitter governing anxiety regulation, sleep onset, and cognitive noise reduction. GAD is P5P-dependent. Low P5P reduces GAD activity, impairing GABA synthesis and shifting the excitatory/inhibitory balance toward excess glutamatergic activation — manifesting as anxiety, poor sleep quality, and cognitive rumination.
Homocysteine Metabolism
P5P is required for cystathionine beta-synthase (CBS) and cystathionase enzymes in the transsulfuration pathway — the route that converts homocysteine to cysteine. Elevated homocysteine is independently associated with cognitive decline, white matter degradation, and accelerated brain atrophy. P5P (with B12 and folate) is the core intervention for homocysteine reduction.
Pre-Activated Form: No Hepatic Conversion Required
Standard pyridoxine supplements must be phosphorylated in the liver to form P5P before they can function as coenzymes. This hepatic conversion step is impaired in individuals with liver dysfunction, riboflavin deficiency, aging-related enzyme decline, or PNPO genetic variants. P5P bypasses this bottleneck entirely — arriving pre-activated and immediately functional as a coenzyme in every tissue it reaches.
What the Research Shows
Vitamin B6 is supported by randomized, controlled trials demonstrating cognitive benefits across anxiety reduction, memory improvement, and brain atrophy prevention in conjunction with B12 and folate. Note: The cited clinical trials used pyridoxine hydrochloride, not P5P. P5P is the active metabolite of pyridoxine; direct RCT evidence for P5P supplementation at 24 mg for these endpoints is not yet available.
Field et al. (2022). Human Psychopharmacology: Clinical & Experimental, 37(6):e2852. 100 mg pyridoxine HCl vs. placebo in 478 young adults (anxiety subsample n=265). Significant reduction in self-reported anxiety; trend toward reduced depression (not statistically significant) at 1 month.
Deijen et al. (1992). Psychopharmacology, 109(4):489-496. 20 mg pyridoxine HCl/day in 76 healthy men aged 70–79. Modestly but significantly improved long-term memory storage.
Smith et al. (2010). PLOS ONE, 5(9):e12244. VITACOG trial. B6 (20 mg) + B12 (0.5 mg) + Folic acid (0.8 mg) for 2 years in 271 randomized adults ≥70 with MCI (168 MRI completers). 30% reduction in brain atrophy rate vs. placebo. Note: B6 was part of a three-nutrient combination (B6 + B12 + folate) — B6’s independent contribution cannot be determined.
Your Daily Dose Across APEX + RESET
Why this dose works: The P5P in both APEX and RESET is the pre-activated coenzyme form — not pyridoxine — bypassing the hepatic phosphorylation bottleneck. The split-dose architecture aligns cofactor delivery with the neurotransmitter systems most active in each phase: catecholamines (dopamine, norepinephrine) during the AM performance window, and serotonin/GABA during the PM recovery phase. This circadian dosing rationale is based on biochemical reasoning, not comparative clinical trials testing split vs. single-dose P5P.
Combined Daily B6 (P5P) — APEX + RESET Protocol
Both doses use pyridoxal-5’-phosphate (P5P) — the bioactive coenzyme form that requires no hepatic conversion. The AM/PM split aligns B6 cofactor availability with the neurotransmitter systems that are most metabolically active in each phase of the circadian cycle.
How Vitamin B6 (P5P) Connects Across the System
P5P is the enzymatic key that unlocks neurotransmitter synthesis across both APEX and RESET. It does not act in isolation — it is the shared cofactor connecting the catecholamine production line in the morning and the serotonin/GABA recovery stack at night.
Catecholamine Production Line
APEX is built around sustained focus, motivation, and attention. The catecholamine system — dopamine, norepinephrine — drives all three. Tyrosine (APEX) provides the amino acid precursor. P5P (APEX) is the AADC coenzyme that completes the L-DOPA → dopamine conversion. Caffeine prolongs dopamine signal duration. Three ingredients, one catecholamine performance output — precursor, coenzyme, and signal amplifier aligned.
PM Neurotransmitter Stack
RESET’s sleep architecture requires two converging systems: serotonin → melatonin synthesis, and GABA-mediated inhibition for sleep onset and maintenance. P5P in RESET is the shared coenzyme for both pathways — AADC (5-HTP → serotonin) and GAD (glutamate → GABA). Tryptophan in RESET provides the 5-HTP precursor. Glycine in RESET provides additional sleep-onset support. P5P is the enzymatic linchpin that activates the PM neurotransmitter system.
AM/PM Neurotransmitter Handoff
The daytime catecholamine cycle (dopamine/norepinephrine) and the nighttime serotonin/GABA cycle are biochemically connected — both require P5P, and serotonin is the precursor to melatonin. The APEX AM dose supports daytime catecholamine synthesis for focus and motivation. The RESET PM dose supports serotonin synthesis for mood stabilization, melatonin precursor production, and GABA production for sleep onset. This is a complete 24-hour neurotransmitter architecture enabled by split-dose P5P delivery.
Key Takeaways
The Neurotransmitter Coenzyme
P5P is required for the synthesis of dopamine, serotonin, GABA, and norepinephrine — the four neurotransmitters governing cognitive performance, mood, anxiety regulation, and sleep quality. Without adequate P5P, the precursor supply chain (tyrosine, tryptophan, glutamate) cannot be converted into active neurotransmitters.
Pre-Activated: No Hepatic Conversion Required
Standard pyridoxine supplements require hepatic phosphorylation to form P5P. This conversion step is rate-limited by liver health, riboflavin status, and genetic variation. Both APEX and RESET use P5P directly — the pre-activated coenzyme — bypassing this bottleneck entirely.
Circadian Split for Full-Cycle Coverage
15 mg in APEX supports daytime catecholamine synthesis (dopamine, norepinephrine for focus and motivation). 9 mg in RESET supports nighttime serotonin and GABA synthesis (for sleep onset, mood stabilization, and recovery). This circadian dosing rationale is based on biochemical reasoning, not comparative clinical trials testing split vs. single-dose P5P.
Homocysteine Protection
P5P is a required cofactor for homocysteine clearance via the transsulfuration pathway. Elevated homocysteine is one of the strongest nutritional predictors of cognitive decline and brain atrophy. The VITACOG trial demonstrated that a three-nutrient combination (B6 + B12 + folate) reduced brain atrophy rates by 30% in adults over 70 with mild cognitive impairment — B6’s independent contribution cannot be determined, but the combination provides a structural neuroprotective benefit beyond the acute neurotransmitter effects.
Frequently Asked Questions
What is P5P and how is it different from regular vitamin B6?
P5P (pyridoxal-5′-phosphate) is the biologically active coenzyme form of vitamin B6. Standard supplements use pyridoxine hydrochloride, which must be converted to P5P in the liver before it can function as a coenzyme. This conversion step is rate-limited by liver health, riboflavin status, and genetic variation. P5P bypasses this bottleneck entirely — arriving pre-activated and immediately functional.
Why does the Primacy protocol split B6 across AM and PM?
Catecholamine demand (dopamine, norepinephrine) peaks during daytime alertness and cognitive work. Serotonin and GABA demand peaks during evening wind-down and sleep preparation. Splitting P5P across APEX (15 mg AM) and RESET (9 mg PM) aligns cofactor delivery with the neurotransmitter systems most active in each circadian phase — a strategy not achievable with a single daily dose.
What neurotransmitters require vitamin B6?
P5P is the obligate coenzyme for the synthesis of dopamine (motivation, reward), serotonin (mood, melatonin precursor), GABA (anxiety regulation, sleep), norepinephrine (alertness, attention), and epinephrine (stress response). These five neurotransmitters collectively govern the core dimensions of cognitive performance and recovery.
Can you get enough B6 from food alone?
While B6 is found in poultry, fish, potatoes, and bananas, NHANES data shows approximately 25% of U.S. adults have plasma PLP below the adequacy threshold. More critically, dietary B6 (as pyridoxine) still requires hepatic conversion to P5P — a step impaired by aging and other factors. Functional P5P insufficiency may be more common than dietary surveys suggest.
Is 24 mg of P5P per day safe?
Yes. The Tolerable Upper Intake Level (UL) for vitamin B6 is 100 mg/day for adults. The Primacy protocol delivers 24 mg total (15 mg AM + 9 mg PM) — well within safe limits. The UL is based on the risk of peripheral neuropathy at very high chronic doses (typically >200 mg/day of pyridoxine), and P5P has a more favorable safety profile than pyridoxine at equivalent doses.
How does B6 help with brain atrophy?
P5P is a required cofactor for homocysteine clearance via the transsulfuration pathway. Elevated homocysteine is one of the strongest nutritional predictors of brain atrophy and cognitive decline. The VITACOG trial demonstrated that a three-nutrient combination — B6 (20 mg) + B12 (0.5 mg) + folate (0.8 mg) — reduced brain atrophy rates by 30% over 2 years in adults over 70 with mild cognitive impairment. B6’s independent contribution cannot be determined from this trial.
References
- [1]Field, D. T., Cracknell, R. O., Eastwood, J. R., Scarfe, P., Williams, C. M., Zheng, Y., & Tavassoli, T. (2022). High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression. Human Psychopharmacology: Clinical and Experimental, 37(6), e2852.View
- [2]Deijen, J. B., van der Beek, E. J., Orlebeke, J. F., & van den Berg, H. (1992). Vitamin B-6 supplementation in elderly men: Effects on mood, memory, performance and mental effort. Psychopharmacology, 109(4), 489–496.View
- [3]Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLOS ONE, 5(9), e12244.View
Upgrade Your Neurotransmitter Architecture
Vitamin B6 (P5P) is one of 28 active ingredients across APEX and RESET, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.